Mississippi Administrative Code › Title 15 - Mississippi Department of Health › Part 22 - Medical Cannabis Program › Subpart 1 - General Provisions › Section 15-22-1.2 - Definitions

Current through June 25, 2024
The following terms shall have the meanings indicated for
				  purposes of the Mississippi State Department of Health's Mississippi Medical
				  Cannabis Program rules and regulations.
1.2.1
Accreditation
- The term
				"accreditation" means being currently deemed as technically competent under
				ISO/IEC 17025:2017 by an international mutual recognition arrangement signatory
				that has been found to meet ISO/IEC 17011, Conformity Assessment-Requirements
				for accreditation bodies accrediting conformity assessment bodies.
1.2.2
Accreditation Body
- The
				term "accreditation body" means an impartial nonprofit organization that
				operates in conformance with the International Organization for Standardization
				(ISO)/International Electrotechnical Commission (IEC) standard 17011 and is a
				signatory to the International Laboratory Accreditation Cooperation (ILAC)
				Mutual Recognition Arrangement (MRA) for Testing.
1.2.3
Acquire
- The term
				"acquire" means coming to possess cannabis by means of any legal source in
				compliance with the Mississippi Medical Cannabis Act (the Act) and any rules
				promulgated under the Act.
1.2.4
Additive
- The term "additive" means any non-cannabis derived
				substance added to regulated cannabis and/or cannabis products to achieve a
				specific technical and/or functional purpose during processing, storage, or
				packaging. Additives may be direct or indirect. Direct additives are used to
				impart specific technological or functional qualities. Indirect additives are
				not intentionally added but may be present in trace amounts as a result of
				processing, packaging, shipping, or storage. Botanically Derived Compounds
				which have been isolated or enriched and subsequently added back into cannabis
				products are additives.
1.2.5
Advertising -
The terms "advertising" and "advertisement" shall
				mean all representations disseminated in any manner or by any means, other than
				labeling, for the purpose of inducing, or which are likely to induce, directly
				or indirectly, the purchase of medical cannabis. Advertising does not include
				labeling as required by the regulations of the Medical Cannabis
				Program.
1.2.6
Affiliate
				-
The term "affiliate" means any entity effectively controlling or
				controlled by another entity or associated with other entities under common
				ownership or control, including a parent or subsidiary.
1.2.7
Agent -
The term "agent"
				means a person who acts for or on behalf of or represents another (e.g.,
				employee, representative).
1.2.8
Allergen -
The term "allergen" means a major food allergen as
				defined in 21 U.S.C §
										321(qq).
1.2.9
Allowable Amount of Medical
				Cannabis
- The term "allowable amount of medical cannabis" means an
				amount not to exceed the maximum amount of Mississippi Medical Cannabis
				Equivalency Units ("MMCEU").
1.2.10
Analytical Batch
- The term "analytical batch" means a set of no
				more than twenty (20) samples that are prepared together for the same type of
				analysis, are sequentially analyzed using the same instrument calibration
				curve, and have common analytical quality control requirements. The batch shall
				include testing samples as well as all applicable quality control
				samples.
1.2.11
Applicant
- Ther term "applicant" means a person who
				registers/applies for an initial work permit or renewal of a work permit who
				must complete a fingerprint-based background check of the Mississippi Central
				Criminal Database and the Federal Bureau of Investigation Criminal History
				Database and must not have a disqualifying felony offense. Once such an
				applicant passes the criminal background check, the applicant may then work
				for, or maintain ownership in, a medical cannabis establishment licensed and
				registered by the Department or MDOR as applicable.
For the purpose of these regulations, the term "applicant"
				  may also be defined as a practitioner, patient, or caregiver, who do not
				  require criminal-based background checks.
1.2.12
Batch
- The term "batch"
				means, with regard to usable medical cannabis, a homogenous, identified
				quantity of usable medical cannabis, no greater than twenty-five pounds (25
				lbs), that is harvested during a specified time period from a specified
				cultivation area, and with regard to oils, vapors and waxes derived from usable
				medical cannabis, means an identified quantity that is uniform, that is
				intended to meet specifications for identity, strength, and composition, and
				that is )d, packaged and labeled during a specified time period according to a
				single manufacturing, packaging and labeling protocol.
1.2.13
Batch Number
- The term
				"batch number" means a unique numeric or alphanumeric identifier assigned to a
				batch by a cultivation or processing entity. The batch number for plant batches
				shall contain the strain name and date created. The batch number for harvest
				batches shall contain the strain name and date harvested. The batch number for
				production batches shall contain the item name and date produced. In the event
				that multiple batches of the same product or item are created on the same date,
				a unique suffix shall be added such as a numeric or alphabetical character.
				(e.g., 1, 2, 3, a, b, c, etc.).
1.2.14
Biosecurity Measures
-
				The term "biosecurity measures" means a set of preventative measures designed
				to reduce the risk of transmission of infectious diseases in crops, quarantined
				pests, invasive alien species, and living modified organisms that could impact
				the safety of cannabis and cannabis products.
1.2.15
Board Member
- The term
				"board member" means an individual serving as a representative on the governing
				body of a medical cannabis establishment.
1.2.16
Botanically-Derived
				Compounds
- The term "botanically-derived compounds" means organic
				chemicals that typically have a high vapor pressure at room temperature and are
				likely to be dispersed into the air. Botanically Derived Compounds include, but
				are not limited to terpenes, terpenoids, ketones, esters, and other molecules
				which are naturally occurring in plants and are used to affect the flavor and
				aroma of cannabis products. Synthetic cannabinoids are not botanically derived
				compounds and are prohibited.
1.2.17
Brand -
The term "brand"
				shall mean a name, term, design or symbol or any other feature that identifies
				one seller's goods or services as distinct from those of other sellers. For
				purposes of these regulations, a company logo is considered a brand.
1.2.18
Branding -
The term
				"branding" shall mean the process of giving a meaning to a specific medical
				cannabis establishment's business by publicizing the business's name and
				logo.
1.2.19
Cannabinoid
				Extract
- The term "cannabinoid extract" means a substance obtained by
				separating cannabinoids from cannabis by any of the following methods:
A. A chemical extraction process using a
				hydrocarbon-based solvent; or
B. A
				chemical extraction process using the hydrocarbon-based solvent carbon dioxide
				if the process uses high heat or pressure.